| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/GLIA.21245 |
| P698 | PubMed publication ID | 21964955 |
| P50 | author | Peter J Van den Elsen | Q40683739 |
| Jeffrey Bajramovic | Q56794153 | ||
| P2093 | author name string | Ivanela Kondova | |
| Hedwich F Kuipers | |||
| Ella A Zuiderwijk-Sick | |||
| Céline Van Der Putten | |||
| Linda Van Straalen | |||
| P2860 | cites work | Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis | Q21144329 |
| Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs | Q24303416 | ||
| Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages | Q24561388 | ||
| Innate immune recognition | Q27860721 | ||
| A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 | ||
| Regulation of the mevalonate pathway | Q29547763 | ||
| Differential effects of statins on relevant functions of human monocyte-derived dendritic cells | Q33230637 | ||
| Statins as potential therapeutic agents in neuroinflammatory disorders | Q34213875 | ||
| Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis | Q34784810 | ||
| Pathogen recognition with Toll-like receptors | Q36159961 | ||
| How Toll-like receptors signal: what we know and what we don't know | Q36339101 | ||
| TLR signaling. | Q36627105 | ||
| Combined medication of lovastatin with rolipram suppresses severity of experimental autoimmune encephalomyelitis | Q37084467 | ||
| Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis | Q37139712 | ||
| Statin therapy inhibits remyelination in the central nervous system. | Q37164252 | ||
| Regulation of innate immune responses in the central nervous system. | Q37818408 | ||
| Effects of statins on microglia | Q40381858 | ||
| Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains | Q40402794 | ||
| Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial | Q43057997 | ||
| Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy | Q43164753 | ||
| The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease | Q43934617 | ||
| Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription factors | Q43963606 | ||
| Statins as immunomodulators: comparison with interferon-beta 1b in MS. | Q44172256 | ||
| Broad expression of Toll-like receptors in the human central nervous system | Q44492400 | ||
| Oral simvastatin treatment in relapsing-remitting multiple sclerosis | Q44897670 | ||
| Statins enhance toll-like receptor 4-mediated cytokine gene expression in astrocytes: implication of Rho proteins in negative feedback regulation | Q44932595 | ||
| Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors on microglia | Q45057128 | ||
| Lovastatin modulation of microglial activation via suppression of functional CD40 expression | Q45066194 | ||
| Differentiation of primary adult microglia alters their response to TLR8-mediated activation but not their capacity as APC. | Q45178138 | ||
| 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate beta-amyloid-induced microglial inflammatory responses. | Q45221796 | ||
| Differential expression of adenosine A3 receptors controls adenosine A2A receptor-mediated inhibition of TLR responses in microglia. | Q45983873 | ||
| Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression | Q46433219 | ||
| Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes | Q46463155 | ||
| Simvastatin affects cell motility and actin cytoskeleton distribution of microglia | Q46736945 | ||
| Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. | Q46916581 | ||
| Negative impact of statins on oligodendrocytes and myelin formation in vitro and in vivo. | Q48743494 | ||
| TLR signaling tailors innate immune responses in human microglia and astrocytes | Q57041985 | ||
| Statins as a newly recognized type of immunomodulator | Q73252634 | ||
| Pravastatin down-regulates inflammatory mediators in human monocytes in vitro | Q73337591 | ||
| Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin | Q78076743 | ||
| [Toll-like receptor] | Q81455322 | ||
| P433 | issue | 1 | |
| P921 | main subject | toll-like receptor | Q408004 |
| microglia | Q1622829 | ||
| microglial inhibitor | Q63100844 | ||
| P304 | page(s) | 43-52 | |
| P577 | publication date | 2011-09-30 | |
| P1433 | published in | Glia | Q15716658 |
| P1476 | title | Statins amplify TLR-induced responses in microglia via inhibition of cholesterol biosynthesis | |
| P478 | volume | 60 |
| Q38396167 | Alternative methods for the use of non-human primates in biomedical research |
| Q58799132 | An Overview of Methods to Study Microglia |
| Q64914715 | Pretreatment with simvastatin upregulates expression of BK-2R and CD11b in the ischemic penumbra of rats. |
| Q41848796 | Statin treatment affects cytokine release and phagocytic activity in primary cultured microglia through two separable mechanisms |
| Q36058919 | Toll-like receptor (TLR) and inflammasome actions in the central nervous system |
Search more.